SLC38A6 and hepatocellular carcinoma: Silencing EP300 reduces the H3K27ac modification near the promoter region of solute carrier family 38 member 6, a factor involved in glutamine metabolism, mitochondrial respiration viability, cell cycle progression, and colony formation in HCC cells [12].